Literature DB >> 10464165

Distinctive roles of Fyn and Lyn in IgD- and IgM-mediated signaling.

K Horikawa1, H Nishizumi, H Umemori, S Aizawa, K Takatsu, T Yamamoto.   

Abstract

Src family kinases Fyn and Lyn associate with the B cell antigen receptor (BCR). Accumulating data show that Lyn plays important roles in BCR-mediated signaling, while the role of Fyn remains obscure. Here we dissected the role of Fyn and Lyn in BCR signaling using B cells from fyn(-/-), lyn(-/-) and fyn/lyn double-deficient (fyn(-/-)lyn(-/-)) mice. In contrast to previous reports, fyn(-/-) B cells were slightly hyporeactive to both anti-IgM and anti-IgD-dextran. Although lyn(-/-) B cells were hyper-reactive to anti-IgM, anti-IgD-induced proliferation was impaired in lyn(-/-) B cells. Most of the other phenotypes of fyn(-/-)lyn(-/-) mice were similar to that of lyn(-/-) mice, except that proliferative responses of B cells to various stimuli, such as BCR cross-linking and lipopolysaccharide, were significantly lower in fyn(-/-)lyn(-/-) mice than in lyn(-/-) mice. Finally, immune responses to thymus-independent type 2 antigen were affected in these mutant mice. These observations suggest that Fyn and Lyn are involved in B cell functions, and play similar, but partly distinct, roles in BCR signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464165     DOI: 10.1093/intimm/11.9.1441

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1).

Authors:  Miranda L Curtiss; Bruce S Hostager; Elizabeth Stepniak; Melody Singh; Natalie Manhica; Judit Knisz; Geri Traver; Paul D Rennert; John D Colgan; Paul B Rothman
Journal:  Mol Immunol       Date:  2011-04-21       Impact factor: 4.407

2.  A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn.

Authors:  Dipak Barua; William S Hlavacek; Tomasz Lipniacki
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

3.  Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways.

Authors:  John C Cambier
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

4.  Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells.

Authors:  Katarzyna M Skrzypczynska; Jing W Zhu; Arthur Weiss
Journal:  Immunity       Date:  2016-11-23       Impact factor: 31.745

6.  The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action.

Authors:  Rong Chen; Jennifer Tsai; Philip A Thompson; Yuling Chen; Ping Xiong; Chaomei Liu; Francis Burrows; Mariela Sivina; Jan A Burger; Michael J Keating; William G Wierda; William Plunkett
Journal:  Blood Cancer J       Date:  2021-03-13       Impact factor: 11.037

7.  Fyn kinase is required for optimal humoral responses.

Authors:  Natalia S Chaimowitz; Yves T Falanga; John J Ryan; Daniel H Conrad
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

8.  Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.

Authors:  Theresa Tretter; Ashley E Ross; Dominic I Dordai; Stephen Desiderio
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

Review 9.  B lymphocyte antigen receptor signaling: initiation, amplification, and regulation.

Authors:  Thomas A Packard; John C Cambier
Journal:  F1000Prime Rep       Date:  2013-10-01

10.  Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.

Authors:  Carlos R Figueiredo; Helen Kalirai; Joseph J Sacco; Ricardo A Azevedo; Andrew Duckworth; Joseph R Slupsky; Judy M Coulson; Sarah E Coupland
Journal:  J Pathol       Date:  2020-04       Impact factor: 7.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.